NEW YORK (Reuters Health) – A recent prospective study disproves earlier observations that non-steroidal anti-inflammatory drugs (NSAIDS) prevent Alzheimer dementia (AD). At best, NSAIDS may delay its onset,…
NEW YORK (Reuters Health) – Stereotactic body radiation therapy (SBRT) for early-stage non-small-cell lung cancer (NSCLC) results in “excellent 3-year local control and survival rates,” researchers report based…
NEW YORK (Reuters Health) – Elderly patients with Alzheimer’s disease treated with second-generation antipsychotics should be monitored closely for weight gain and dyslipidemia, according to an analysis of…
NEW YORK (Reuters Health) – Three milligrams of melatonin at bedtime can effectively treat sleep problems in children with autistic spectrum disorder or fragile X syndrome or both,…
NEW YORK (Reuters Health) – Certain women may be at risk of developing systemic lupus erythematosus (SLE) when they start taking combined oral contraceptives, according to investigators at…
NEW YORK (Reuters Health) – The two commercially available Mycobacterium tuberculosis-specific interferon-gamma release assays show excellent agreement with each other. As far more accurate indicators of latent TB…
NEW YORK (Reuters Health) – The results of a postmortem study indicate that elderly people who commit suicide usually do not have antidepressant medications in their systems at…
NEW YORK (Reuters Health) – In patients with newly diagnosed type 1 diabetes, high-dose immune ablation followed by autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) induces significant and…
NEW YORK (Reuters Health) – Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, is a safe and effective treatment for hot flushes in postmenopausal women, according to a report in the…
NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes,…
